Trials / Terminated
TerminatedNCT02890875
Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Patients on long-term parenteral nutrition (PN) are at high risk for central line-associated bloodstream infections (CLABSI). This study evaluates the efficacy and safety of ethanol lock therapy for CLABSI prophylaxis in adult patients on PN.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ethanol lock | |
| OTHER | Heparin lock |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
- First posted
- 2016-09-07
- Last updated
- 2019-05-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02890875. Inclusion in this directory is not an endorsement.